ACE2 decoy receptor with robust neutralization against Omicron subvariants shows therapeutic potential
Researchers demonstrated the inhalation of an ACE2 decoy receptor, sACE22.v2.4-IgG1, increases survival and ameliorates lung injury in K18-hACE2 transgenic mice.